Prevalence of Cancelled Shock Therapy and Relationship to Shock Delivery in Recipients of Implantable Cardioverter-Defibrillators Assessed by Remote Monitoring

Background: Cancelled shock therapy (CxTx) may presage shock delivery and shorten battery longevity of implantable cardioverter-defibrillators (ICDs). However, it is silent and has received little attention. Remote home monitoring (HM) with continuous surveillance and automatic daily data archiving allows investigation of CxTx. Methods and Results: We retrospectively analyzed a database of 4,960 recipients of HM ICD, from 2002 to 2007. Over a mean follow-up of 445 +/- 253 days, CxTx occurred in 1,392 (28%) patients, mostly as single episodes (n = 1,120). However, 142 patients (10% of patients with CxTx, 2.9% of the whole ICD population) had >10 CxTx. CxTx was followed by shock delivery in 432 patients, in 239 (55%) of whom CxTx occurred >10 days prior to shock delivery. In 113 patients (26%), CxTx occurred in the 72-hour period preceding the shock. A single CxTx preceded the shock in 74 of these 113 patients, and only eight patients had >3 CxTx. Conclusion: CxTx was highly prevalent in unselected ICD recipients, though the intraindividual density of episodes was low. In 2.9% of the overall population, the number of CxTx was sufficient to shorten the battery longevity. A high number of CxTx usually did not predict the delivery of shocks. (PACE 2009; 32:S42-S46)